Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"factor XI"”.
-
FACTOR XI ACTIVATION AND INHIBITION IN CATHETER-INDUCED CLOTTING
… to manage and prevent catheter-induced clotting. Factor (F) XI in the contact pathway of coagulation has emerged as a promising target for anticoagulant therapy because FXI is key for blood clot formation but is not essential in normal blood clotting. Consequently, FXI inhibitors have become a …
-
Structural Determinants for Heparin Binding in Human Coagulation Factor XI
Coagulation factor XI plays an important role in the consolidation phase of blood coagulation. Previous studies from our laboratory and others have demonstrated that zymogen factor XI (FXI) binds to heparin with moderate (KD~110 nM) affinity via residues (K252, K253 and K255) located in the apple 3 …
-
The Role of Thrombin Exosites 1 and 2 in the Activation of Factor XI by Thrombin
Factor XI (FXI) is the zymogen of the coagulation protease factor XIa (FXIa) that contributes to thrombin generation through the intrinsic pathway. FXI is activated by the contact pathway protease, factor XIIa (FXIIa), in a high molecular weight kininogen-dependent manner. It is also known to be …
-
The development of an assay and method of purification for human blood clotting factor XI (plasma thromboplastin antecedent)
Thesis (Ph.D.)--Michigan State University. Department of Chemistry, 1965
-
Analysis of the factor XII-driven contact system activation in vivo
… bound to and activated the plasma protease factor XII. PolyP-driven factor XII-activation triggered release of the inflammatory mediator bradykinin by plasma kallikrein-mediated kininogen processing. PolyP increased vascular permeability and induced fluid extravasation in skin microvessels …
-
Evaluation of DOAC-Stop to Reverse the Effects of Factor XIa Inhibitors on the Activated Partial Thromboplastin Time
Factor (F) XI is a serine protease involved in the intrinsic pathway of coagulation. This protein is an emerging target for anticoagulation due to its presumed minor role in hemostasis, but major role in thrombosis. FXI and activated FXI (FXIa) inhibitors are promising alternatives to traditional …
-
Computational Modeling And Simulation Of Thrombus Formation
… results discloses that the intrinsic protease factor XI could be an excellent therapeutic target for thrombosis treatment with the advantage of not affecting hemostasis. Chapter 6 describes the effect of flow on the initiation of arterial clotting under conditions of exposed tissue factor (TF). …
-
Investigations on beta 2-glycoprotein I and antiphospholipid antibodies
… platelet surface, including binding coagulation factor XI (FXI). The implication of the interaction between β2GPI and GPIbα on platelet activation and the release of thromboxane in the presence of anti-β2GPI antibodies is explored, as well as the intracellular pathways via which this activation …
-
Aging and design of concrete members reinforced with GFRP bars
… fatigue loads was clearly demonstrated. Maximum concrete strains at working loads should be preferably well below 750 x 10-6 (25% of epsiloncu) for GFRP reinforced concrete beams designed for compression failure due to fatigue considerations. In addition, conservative reduction factor of …
-
The role of hypercoagulability in neurovascular disorders: insights from clinical epidemiology
… preserving the hemostatic balance, coagulation factors are of great interest in the context of both venous and arterial thrombosis. Recent laboratory work has indicated that a hypercoagulable state increases risk for ischemic events. Furthermore, first clinical trials have found that temporarily …
-
Das prokoagulatorische Potential hoher Faktor XI-Spiegel bei der venösen Thromboembolie
Hoher Faktor XI stellt einen Risikofaktor der venösen Thrombose dar, über welchen Mechanismus hohe Faktor XI-Spiegel dabei thrombogen wirken ist noch weitestgehend unklar. Denkbar wäre eine Faktor XI-abhängige gesteigerte Thrombingenerierung. Andererseits ist eine gesteigerte Thrombingenerierung …
-
Haemostatic factors in diabetes mellitus with particular reference to thrombotic disease
… significantly higher levels of fibrinogen, factors II, V, VII, VIII:C, OC^-macroglobulin and c^-esterase inhibitor and lower levels of factor XI and antithrombin III were found, though the threshold concentrations of ADP, adrenaline and collagen required to produce second phase platelet …
-
ASSESSING DRUG DEVELOPMENT PROPORTIES OF ANTITHROMBOTIC AND ANTI - CANCER AGENTS
… Several lines of evidence have suggested that factor XIa (FXIa) is a promising target for developing a new line of anticoagulants with a potentially minimal risk of bleeding [6, 7]. For example, hemophilia C patients with congenital FXI (Factor XI) deficiency are known to suffer minimal …
-
LOCALIZATION OF LIGAND-BINDING EXOSITES IN THE CATALYTIC DOMAIN OF FXIa AND DETERMINATION OF THE ROLES OF CALCIUM AND THE HEAVY CHAIN OF FXIa IN FIX ACTIVATION BY FXIa
Coagulation factor XI (FXI) is a plasma zymogen that is activated to FXIa, the catalytic domain of which contains exosites that interact with its normal macromolecular substrate (FIX), and its major regulatory inhibitor (protease nexin-2 kunitz protease inhibitor, PN2KPI). To localize the catalytic …
-
Mechanism of Catheter Thrombosis and Approaches for its Prevention
… the blood coagulation cascade to produce factor (f) Xa, the clotting enzyme that induces thrombin generation. By activating platelets and converting soluble fibrinogen to fibrin, thrombin leads to blood clot formation. Blood clots that form on medical devices create problems because they …